Fifteen Years of Immunological Follow-up of Women Who Received One, Two and Three Doses of the Bivalent HPV Vaccine in the CVT (Costa Rican HPV-16 18 Vaccine Trial) or the CVT EXTEND Study
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 23 Mar 2018
At a glance
- Drugs Human papillomavirus vaccine recombinant bivalent Japan Vaccine/MedImmune (Primary)
- Indications Cervical cancer; Human papillomavirus infections
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms CVT EXTEND
- 20 Mar 2018 Planned initiation date changed from 2 Mar 2018 to 26 Mar 2018.
- 27 Feb 2018 Planned initiation date changed from 28 Feb 2018 to 2 Mar 2018.
- 22 Feb 2018 Planned initiation date changed from 1 Feb 2018 to 28 Feb 2018.